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ABSTRACT
Computational techniques have been used to de-
sign a novel class of RNA architecture with expected
improved resistance to nuclease degradation, while
showing interference RNA activity. The in silico de-
signed structure consists of a 24–29 bp duplex RNA
region linked on both ends by N-alkyl-N dimeric nu-
cleotides (BCn dimers; n = number of carbon atoms
of the alkyl chain). A series of N-alkyl-N capped
dumbbell-shaped structures were efficiently synthe-
sized by double ligation of BCn-loop hairpins. The
resulting BCn-loop dumbbells displayed experimen-
tally higher biostability than their 3′-N-alkyl-N linear
version, and were active against a range of mRNA
targets. We studied first the effect of the alkyl chain
and stem lengths on RNAi activity in a screen in-
volving two series of dumbbell analogues target-
ing Renilla and Firefly luciferase genes. The best
dumbbell design (containing BC6 loops and 29 bp)
was successfully used to silence GRB7 expression
in HER2+ breast cancer cells for longer periods of
time than natural siRNAs and known biostable dumb-
bells. This BC6-loop dumbbell-shaped structure dis-
played greater anti-proliferative activity than natural
siRNAs.
INTRODUCTION
RNA interference (RNAi) is an innate defense mechanism
of gene regulation triggered by 21–23 nt RNA duplexes
with 3′-terminal dinucleotide overhangs (siRNAs) (1,2) that
are generated in the cytoplasm by Dicer cleavage of longer
RNAs (3–5). After incorporation into the RISC protein
complex, siRNAs induce degradation of the complemen-
tary target mRNAs. Shortly after the discovery of RNAi,
synthetic siRNAs were found to produce the same effect
(6,7). Since then, much effort has been made to exploit the
RNAi process experimentally to inhibit the expression of
genes of choice for therapeutic purposes (8,9). However, de-
spite the attractive biomedical potential of this approach,
siRNAs are not drug-like molecules. One of their most im-
portant limitations is their vulnerability to degradation by
serum exo- and endonucleases (10,11).
Extensive research has been conducted to increase the
biostability of these agents (8,9). These efforts have yielded a
wide number of siRNAs containing chemical modifications
in the sugar ring or the phosphate backbone (8,9,12–20).
Relevant examples are siRNAs that incorporate electroneg-
ative substituents at the 2′-position in the sugar ring such
as 2′-fluoro (12–16) and 2′-O-methyl substitutions (17,18),
which are known to increase the biostability and thermal
stabilities of siRNAs to a great extent (21–24). Another
modification that has been widely studied is the phospho-
rothioate linkage (PS) (19,20).
Two main approaches are usually considered in order to
increase nuclease resistance. The first one is based on the
extensive modification of the RNA molecule. For example,
Sirna Therapeutics has several products that involve combi-
nation of 2′-fluoro pyrimidines, DNA purines, PS linkages
and abasic caps (9) in the sense and the guide strands. These
combinations have yielded products of increased potency
and long serum half-life (48–72 h) that have been success-
fully used in aHepatitis B virusmousemodel (25).However,
the extensive modification of the siRNA molecules often
is not-well tolerated by the RNAi machinery and can lead
to the reduction of the gene silencing activity (7,17). The
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selective modification of the nuclease-sensitive sites repre-
sents an alternative approach to the extensive modifica-
tion of the siRNA. For example, Alnylam Pharmaceuti-
cals has several siRNA products that are selectively mod-
ified with 2′-O-methyl or 2′-fluoro substitutions at vulner-
able sites (9,26) (http://www.alnylam.com/Programs-and-
Pipeline/index.php). Therefore, development of minimal
modification approaches aimed at improving or optimizing
the properties of the siRNAmolecule (e.g. by protecting the
3′-terminal ends of the duplex from exonuclease cleavage)
are of significance nowadays.
With the aim of developing new and complementary ap-
proaches for modifying the siRNA molecule, in a recent
study, we developed a new class of 3′-exonuclease-resistant
modification (27) that involved minimal and selective alter-
ation of the oligonucleotide. In particular, our strategy in-
volved replacement of the 3′-terminal natural dinucleotide
overhangs of siRNAs by dimeric nucleotides composed of
two 2′-deoxy-5-methylcytidine units linked together by an
ethyl chain through the exocyclic amino group of the nu-
cleobase (N-ethyl-N bridged nucleosides). Based on the
promising results of those studies, here we have under-
taken a computational investigation of the conformational
and dynamic behavior of 3′-terminal N-alkyl-N bridged nu-
cleotides (BCn dimers; n = number of carbon atoms of the
alkyl chain) that has allowed us to develop new RNA archi-
tectures with even higher nuclease resistance. In particular,
dumbbell-shaped structures having a duplex RNA region
comprised of 24–29 base pairs linked on both ends by BCn
dimers (Figure 1).
There are only a few reports in the literature of dumbbell-
shaped dsRNAs acting as siRNA precursors (28–30). Two
relevant examples are nuclease-resistant RNA dumbbells
with loops composed of seven natural nucleotides linked
by standard phosphodiester bonds (28) and dimeric 1,2-
bis(maleimido)ethane crosslinkers (29), which have been
used to silence the expression of transiently transfected lu-
ciferase genes. In particular, the 7 nt-loop dumbbells were
found to display significantly longer RNAi effect in cell cul-
ture than natural siRNA (28).
In view of the similarity between the BCn and 7 nt-
loop dumbbells and the longer-lived RNAi activity of these
structures, we decided to use them as controls in our stud-
ies. Stability studies in serum and cytosol cell extract con-
firmed that our BCn-loop design was more stable than the
7 nt-loop dumbbells described in the literature (28). More-
over, the best BCn-loop dumbbell design could be success-
fully applied to inhibit GRB7 (31) expression in HER2+
breast cancer cells and showed longer inhibitory effect than
natural siRNA and their 7 nt-loop analogues (28). To our
knowledge, the present work is the first example that pro-
vides data on long-term inhibition of endogenous genes in-
duced by dumbbell-shaped RNAs.
MATERIALS AND METHODS
RNA synthesis
Oligonucleotide sequences that did not contain mod-
ified nucleotides were purchased from Sigma Aldrich.
All modified sequences were synthesized at the 1 mol
scale via solid phase synthesis using standard phospho-
ramidite methods (32). Reagents for oligonucleotide syn-
thesis including 2′-O-TBDMS-protected phosphoramidite
monomers of ABz, CAc, Gdmf and U, solid chemical
phosphorylation reagent (5′-phosphate), the 5′-deblocking
solution (3% TCA in CH2Cl2), activator solution (0.3
M 5-benzylthio-1-H-tetrazole in CH3CN), CAP A solu-
tion (acetic anhydride/pyridine/THF), CAP B solution
(THF/N-methylimidazole 84/16) and oxidizing solution
(0.02 M iodine in tetrahydro-furan/pyridine/water (7:2:1))
were obtained from commercial sources.
For the synthesis of RNA strands containing BCn
loops, commercially available 5′-O-DMT-ABz-3′-succinyl-
LCAA-CPG, 5′-O-DMT-CAc-3′-succinyl-LCAA-CPG, 5′-
O-DMT-Gdmf-3′-succinyl-LCAA-CPG and 5′-O-DMT-U-
3′-succinyl-LCAA-CPG were used as the solid supports.
For the synthesis of 3′-BC2-modified RNA strands, CPG
functionalized with a BC2 unit (27) was used as the solid
support. The coupling time was 15min. The coupling yields
of natural and modified phosphoramidites were around
95%. Incorporation of the dimeric nucleoside modification
did not have a negative effect in the yield. Terminal 5′-
phosphate group was incorporated by using the commer-
cially available solid chemical phosphorylation reagent. All
oligonucleotides were synthesized in DMT-OFF mode.
Deprotection and purification of unmodified and modified
RNA oligonucleotides
After the solid-phase synthesis, the solid support was trans-
ferred to a screw-cap vial and incubated at 55◦C for 2 h
with 1.5 ml of NH3 solution (33%) and 0.5 ml of ethanol.
The vial was then cooled on ice and the supernatant was
transferred into a 2 ml eppendorf tube. The solid support
and vial were rinsed with 50% ethanol (2 × 0.25 ml). The
combined solutions were evaporated to dryness using an
evaporating centrifuge. The residue that was obtained was
dissolved in 1 M TBAF in THF (330 l) and incubated
at room temperature for 15 h. Then, 1 M triethylammo-
nium acetate (TEEA) and water were added to the solu-
tion (330 l TEEA and 330 l water). The oligonucleotides
were desalted on NAP-10 columns using water as the elu-
ent and evaporated to dryness. The oligonucleotides were
purified by 20% polyacrylamide gel electrophoresis (DMT-
OFF). After purification, the RNAs were isolated by the
crush and soak method, dialyzed, quantified by absorp-
tion at 260 nm and confirmed by Matrix-Assisted Laser
Desorption/Ionization (MALDI) mass spectrometry (see
Supplementary Table S1).
For annealing of linear siRNAs, 20 M single strands
were incubated in siRNA buffer (100 mM KOAc, 30 mM
HEPES-KOH at pH 7.4, 2 mM MgCl2) for 1 min at 90◦C
followed by 1 h at 37◦C.
Enzymatic synthesis of RNA dumbbells using T4 RNA ligase
2
Final composition of the reaction mixture (250 l) was as
follows: 2 M 5′-phosphorylated-dsRNA, 22.5 units T4
RNA ligase 2 (New England Biolabs), 50 mM Tris-HCl
(pH 7.5), 2 mM MgCl2, 1 mM DTT, 400 M ATP. Af-
ter 5′-phosphorylated RNAs had been annealed, T4 RNA
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Figure 1. BCn loops and RNA structures used in this study. The 29 bp RNAs 2a-c, 24 bp RNAs 9a,b and 29 bp RNAs 14 and 18 (and the corresponding
linear controls siRNA I, siRNA II, siRNA III and siRNA IV, and 7 nt-loop dumbbell analogues 5, 10, 15 and 19) target the Renilla and Firefly mRNAs and
the 1019–1037 and 943–962 sites in the GRB7 mRNA. Top strand depicts the sense strand in the 5′→3′ direction (same as the target sequence). Bottom
strand depicts the antisense strand in the 3′→5′ direction (complementary to the target). BCn: N-alkyl-N dimeric nucleoside; n: number of carbon atoms
of the alkyl chain; scr: scrambled sequence; p: 5′-terminal phosphate group.
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ligase 2 (New England Biolabs) was added to the concen-
trations described above and incubated at 37◦C overnight.
The RNA was precipitated by the addition of ethanol and
sodium acetate (pH 5.2). Ligated products were purified
by preparative (1 mm thick) denaturing PAGE (10%PAGE,
25% formamide, 7 M urea in 1X TBE). Bands were visual-
ized by UV shadowing, and crushed and extracted with 0.1
M NaCl. The eluate was desalted by using Slide-A-Lyzer
dyalisis columns (ThermoFischer Scientific).
Dicer cleavage reaction of RNAs
RNAs (0.91 M) were mixed with Dicer enzyme (0.091
units/l; Recombinant Human Turbo Dicer Enzyme Kit
from Genlantis, USA) in the buffer system supplied. The
mixtures were incubated at 37◦C and aliquots (2.2 l) were
taken from the mixture after 0, 1, 6 and 20 h. They were
analyzed by 15% non-denaturing PAGE. The gels were vi-
sualized with SYBR Gold.
UV-monitored thermal denaturation studies
Absorbance versus temperature curves of duplexes Ld-
sRNA24, 9a, 9b and 10 were measured at 1 M strand con-
centration in 10mMphosphate buffer (pH 7.0) containing 1
mM EDTA. In the case of duplexes LdsRNA29, 2a and 2b,
10 mM phosphate, 5 mM EDTA buffer (pH 7.0) was used.
Experiments were performed in Teflon-stoppered 1 cm path
length quartz cells on a Varian-Cary-100 spectrophotome-
ter equipped with thermoprogrammer. The samples were
heated to 100◦C, allowed to slowly cool to 20◦C, and then
warmed during the denaturation experiments at a rate of
0.5◦C/min to 100◦C, monitoring absorbance at 260 nm.
The data were analyzed by the denaturation curve process-
ing program, MeltWin v. 3.0. Melting temperatures (Tm)
were determined by computerfit of the first derivative of ab-
sorbance with respect to 1/T.
Cell culture
All cell lines (HeLa, HeLa H/P, SKBR3 and MCF7) were
mantained at 37◦C in a humidified atmosphere with 5%
CO2. HeLa and MCF7 cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM;GIBCO) supplemented
with fetal bovine serum (FBS, 10%), penicillin (100 U
ml−1) and streptomycin (100 g ml−1). SKBR3 cells were
cultured in McCoy’s modified medium (GIBCO) supple-
mented with FBS (10%), penicillin (100 U ml−1) and strep-
tomycin (100 g ml−1). HeLa H/P cells stably expressing
pGL4.14 [luc2/Hygro] (Promega) and pRL-tk-Puro (a kind
gift ofDrAlagia) weremaintained under hygromycin B (200
g ml−1) and puromycin (2 g ml−1) selection pressure.
Luciferase siRNA assays
HeLa cells were regularly passaged to mantain exponen-
tial growth. The cells were seeded one day prior to the
experiment in a 24-well plate at a density of 1.5 x 105
cells/well in complete DMEM containing 10% FBS (500
l per well). Following overnight culture, the cells were
treated with luciferase plasmids and siRNAs. Two lu-
ciferase plasmids––Renilla luciferase (pRL-TK) and firefly
luciferase (pGL3) from Promega––were used as a reporter
and control. Cotransfection of plasmids and siRNAs was
carried out with Lipofectamine 2000 (Life Technologies)
as described by the manufacturer for adherent cell lines;
pGL3-control (1.0 g), pRL-TK (0.1 g) and siRNA du-
plex (20 nM) formulated into liposomes were added to each
well with a final volume of 600l. After a 5-h incubation pe-
riod, cells were rinsed once with phosphate buffered saline
(PBS) and fed with 600 l of fresh DMEM containing 10%
FBS. After a total incubation period time of 22 h, the cells
were harvested and lysedwith passive lysis buffer (100l per
well) according to the instructions of the Dual-Luciferase
Reporter Assay System (Promega). The luciferase activities
of the samples were measured with a MicroLumaPlus LB
96V (Berthold Technologies) with a delay time of 2 s and an
integration time of 10 s. The following volumes were used:
20 l of sample and 30 l of each reagent (Luciferase As-
say Reagent II and Stop and Glo Reagent). The inhibitory
effects generated by siRNAs were expressed as normalized
ratios between the activities of the reporter (Renilla or Fire-
fly) luciferase gene and the control (Firefly or Renilla, re-
spectively) luciferase gene.
Statistical analysis
Data were analyzed by using the GraphPad Prism 5 pro-
gram (GraphPad Software). Where appropriate, the results
are expressed as mean ± standard deviation (SD). P-values
of 0.05 or less were accepted as indicators of statistically
significant data. Significant differences were assessed by
Student’s t-tests or by ANOVA to compare three or more
groups followed by Bonferroni test. Each experiment was
performed in triplicate.
Analysis of GRB7 protein knockdown by Western blot
SKBR3 cells were seeded 24 h before transfection in 60 mm
dishes at a density of 8 x 105 cells/dish in medium contain-
ing 10% FBS. Following overnight culture, siRNA duplexes
(60 nM per dish) formulated into liposomes were added to
each dish with a final volume of 6ml. Cotransfection of siR-
NAs was carried out using Lipofectamine 2000. After a 5-
h incubation period, the transfection medium was changed
to complete medium containing 10% FBS. After a 24-h,
48-h, 72-h and 6-days incubation time, the cells were har-
vested with PBS and lysed by incubation in RIPA buffer
containing protease inhibitors (Roche) at 4◦C for 1 h. Cell
debris were removed by centrifugation at 8000 xg for 20
min at 4◦C, and protein concentration was determined us-
ing the BCA assay (Pierce). Thirty micrograms of protein
were resolved by SDS electrophoresis and transferred to a
poly(vinylidene difluoride) membrane (Immobilon-P, Mil-
lipore). The membrane was blocked with 5% skim milk
in TBS containing 0.1% Tween for 1 h at r.t. and subse-
quently probed with anti-GRB7 monoclonal rabbit anti-
body (Santa Cruz Biotechnology) (diluted 1:1000 in block-
ing buffer) overnight at 4◦C. Anti-rabbit (goat) IgG HRP
conjugated secondary antibody (Thermo Scientific, Rock-
ford, IL, USA) was incubated at 1:5000 dilution in the
blocking solution for 1 h at r.t. -Actin was selected as in-
ternal control and was detected by incubation with anti-
-actin HRP conjugated antibody (Abcam) (at a dilution
 by guest on June 17, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
4358 Nucleic Acids Research, 2016, Vol. 44, No. 9
of 1:20 000 in blocking buffer) for 1 h at r.t. The intensi-
ties of the bands were analyzed using ImageJ 1.45 software
(Rasband,W.S., ImageJ, U. S.National Institutes ofHealth,
Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997–
2011).
Cell proliferation assay
Interference with in vitro growth rate of SKBR3 andMCF7
cells by natural siRNAs and BC6-loop dumbbell was mea-
sured using crystal violet. 1.5 x 105 SKBR3 andMCF7 cells
were plated in 24-well plates. Twenty-four hours after plat-
ing (0 h) cells were transfected with control GRB7 siRNA
III, BC6-loop dumbbell 13 and non-targeting (anti-Renilla)
siRNA I (60 nM) using Lipofectamine 2000. At different
time points (48 or 72 h) cells were fixed with 4% formalin for
10 min, then washed twice with distilled water and stained
with 0.1% freshly prepared crystal violet for 30 min. After
washing, the stain was dissolved with 10% acetic acid and
subsequently quantified by absorbance at 570 nM.
3′-exonuclease digestions
Each RNA oligomer (120 pmol) was incubated with Phos-
phodiesterase I fromCrotalus adamanteus venom (SNVPD;
340 ng, 10 mU or 680 ng, 20 mU) in a buffer containing 56
mM Tris-HCl (pH 7.9) and 4.4 mM MgSO4 (total volume
= 40 l) at 37◦C. At appropriate periods of time, aliquots
of the reaction mixture (5 l) were taken and added to a
solution of 0.5 M EDTA, pH 8.0 (15 l), and the mix-
tures were immediately frozen. The samples were analyzed
by electrophoresis on 15% polyacrylamide gel under non-
denaturing conditions. The oligonucleotide bands were vi-
sualized with the SYBR Gold reagent.
Calf intestinal phosphatase-5′-exonuclease digestions
Each RNA oligomer (120 pmol) was incubated with Calf
Intestinal Phosphatase (1 mU) in a buffer containing 50
mM potassium acetate, 20 mM Tris-acetate, 10 mM mag-
nesium acetate 100 g/ml BSA, pH 7.4 at 37◦C for 30
min. The enzyme was deactivated by heating at 65◦C for
10 min and the RNA products were ethanol precipitated.
After resuspension with 40 l of 100 mM sodium acetate
pH 6.5 buffer, the RNA samples were treated with Bovine
Spleen Phosphodiesterase (10 mU) and incubated at 37◦C.
At appropriate periods of time, aliquots of the reactionmix-
ture (5 l) were taken and added to a solution of 0.5 M
EDTA pH 8.0 (15 l), and the mixtures were immediately
frozen. The samples were analyzed by electrophoresis on
15% polyacrylamide gel under non-denaturing conditions.
The oligonucleotide bands were visualized with the SYBR
Gold reagent.
Stability of RNA and DNA oligonucleotides in PBS contain-
ing human serum
Each oligonucleotide (300 pmol) was incubated in PBS con-
taining 50%of human serum (total volume= 75l) at 37◦C.
At appropriate periods of time, aliquots of the reactionmix-
ture (5 l) were separated and added to a solution of 0.5 M
EDTA pH 8.0 (15 l), and the mixtures were immediately
frozen. The samples were run on a 15% polyacrylamide
gel under non-denaturing conditions. The oligonucleotide
bands were visualized with the SYBR Gold reagent.
Stability of RNA and DNA oligonucleotides in S100 HeLa
cell cytosol extract
Each oligonucleotide (100 pmol) was incubated in 20 mM
HEPES-Na pH 7.9, 42 mM ammounium sulfate, 0.2 mM
EDTA, 0.5 mM DTT, 20% glycerol buffer containing 10%
HeLa cell cytosol extract (S100, human; Jena Bioscience)
at 37◦C. At appropriate periods of time, aliquots of the re-
action mixture (3.7 l) were separated and added to a so-
lution of 0.5 M EDTA pH 8.0 (6.7 l), and the mixtures
were immediately frozen. The samples were run on a 15%
polyacrylamide gel under non-denaturing conditions. The
oligonucleotide bands were visualized with the SYBRGold
reagent.
Molecular dynamics simulations
We simulated four systems, BC2-, BC6- andBC8-dumbbells
(2a, 2b and 2c, respectively), as well as the linear dsRNA
duplex analogue (LdsRNA29), used as a control system.
The approach was similar to that used in previous study
(27). Linker structures were first geometrically optimized
using Gaussian09 (33) package from which were calculated
point charges using RESP calculation (34). Simulations
were done using AMBER14 package (35). We used the lat-
est DNA force-field, parmbsc1 (36) with newRNAparame-
ters developed recently in the lab. RNA structures were cre-
ated using generic NAB module from AMBER14 package.
The structures were solvated with TIP3P water molecules
(37), neutralized with Na+ ions (38) with an additional 0.15
M of Na+Cl− added to the system, in order to approxi-
mate experimental conditions. Systems wereminimized, an-
nealed and equilibrated following the standard AMBER
simulation protocol, with 1 ns of equilibration time. Data
were analyzed using Curves+ program (39).
Molecular Dynamics (MD) simulations of the
double-stranded RNA containing 3′-terminal 1,2-di(5-
methylcytidin-N4-yl)ethane units (1; Figure 1) were
performed using the same approach.
RESULTS AND DISCUSSION
Design of N-alkyl-N capped RNA structures
We started our study by performing MD simulations of a
19 bp siRNA complementary to the 501–519 A-rich site
of the Renilla luciferase mRNA, where each 3′-terminal
dinucleotide overhang (TpT) had been replaced by a BC2
dimer (RNA 1, Figure 1). Interestingly, starting from an
intramolecular stacked conformation, the BC2 dimer pro-
gressed to a completely extended form during the course
of the simulations, with the final snapshot revealing favor-
able stacking interactions between the nucleobase of the sec-
ond subunit of the dimer and the 5′-terminal nucleobase
of the complementary strand (Figure 2A), suggesting that
we could take advantage of the flexibility of the dimer to
create a closed dumbbell-shaped dsRNA with the 3′- and
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Figure 2. (A) Representative snapshot from the molecular dynamics (MD) trajectory of the RNA duplex 5′-UUUUUCUCCUUCUUCAGAUBC2–
3′:3′-BC2AAAAAGAGGAAGAAGUCUA-5′ (1; Figure 1) showing a completely extended conformation of the BC2 dimer, with stacking interactions
between its second subunit and the 5′-terminal nucleobase of the complementary strand. (B) Comparison of average structures of BC2- (yellow), BC6- (red)
and BC8-dumbbells (green) with linear dsRNA (LdsRNA29; blue) fromMD simulations. (C–F) RMSd plots of (C) linear LdsRNA29, (D) BC2-, (E) BC6-
and (F) BC8-dumbbell structures with sequence 5′-AACCAUUUUUUCUCCUUCUUCAGAUUUGA-3′:3′-UUGGUAAAAAAGAGGAAGAAGUC-
UAAACU-5′. Representative snapshots are shown on the right side of each plot. Blue line shows RMSd evolution considering all residues, while green
line shows only the linear part of the dumbbells. Linker structures are drawn with licorice representation, while the linear part is drawn in blue surface
representation. Several of BC6- and BC8-dumbbell snapshots are shown to demonstrate the higher flexibility of those structures compared with BC2-
linker.
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5′-ends connected by a N-alkyl-N bridged nucleoside. To
investigate this possibility, we proceeded to perform MD
simulations of the predicted closed structure. It has been
reported that the efficiency of Dicer processing increases
with the length of the stem of the duplex (28). In particu-
lar, 29 bp dumbbells with loops of natural nucleotides have
been found to act as better substrates for Dicer than shorter
analogues. Thus, the final dumbbell-shaped structures were
designed to have 29 base pairs targeting the same Renilla
mRNA region. To identify the appropriate structural con-
ditions needed for minimal constraints within the double-
stranded RNA, three dumbbells with different alkyl chain
lengths––2, 6 and 8 carbon atoms––were subjected to inves-
tigation (BC2-, BC6- and BC8-loop dumbbells 2a-c, respec-
tively; Figures 1 and 2B, D–F). As a control, we run MD
simulations of their linear counterpart (LdsRNA29; Figures
1 and 2C). Interestingly, the capping of the dsRNA through
BC2, BC6 and BC8 cross-linking did not alter the global ge-
ometry of the double helix. Average structures from 250 ns
MD simulations (Figure 2B) revealed minimal differences
in linear parts of the dumbbells compared with the control
simulation (LdsRNA29). RMSd plots demonstrated stabil-
ity of the proposed structures with neglectable effect of de-
signed linkers on the linear part of the dumbbells (Figure
2, panels C–F). Represented snapshots in Figure 2D–F and
Supplementary Figure S2 show higher flexibility of BC6-
and BC8- linkers with one of its bases being stacked most
of time. As expected, BC8- explored bigger conformational
space taking into account its higher degrees of freedom. In
the case of the BC2- linker, both of its bases kept stacking
with the neighboring base-pair during thewhole simulation.
In terms of helical characteristics linear part of dumbbell
structures are indistinguishable to its analogue counterpart,
LdsRNA29 (see Supplementary Figure S1).
Synthesis of N-alkyl-N capped dumbbell RNAs
Encouraged by these observations, we explored the pos-
sibility of formation of these BC2-, BC6- and BC8-loop
29 bp dumbbells (2a–c; Figure 1). Our synthetic approach
involved double ligation of a pair of hairpins with BCn
loops and 5′-phosphorylated dangling ends (Figure 3A).
The construction of these nanostructures began by synthe-
sizing the BCn-loop dimeric nucleosides according tometh-
ods described previously (see the Supporting Information)
(27,40). The resulting dimers were converted to the desired
phosphoramidites (Scheme S1), which were incorporated
into the BCn-loop internal position of a set of pairs of hair-
pins (pairs 3a-c:4a-c; Figure 3A) by using an automated
DNA/RNA synthesizer and 2′-O-TBDMS-protected phos-
phoramidites of natural ribonucleotides.
Each pair of hairpins (3a:4a, 3b:4b and 3c:4c) was incu-
bated with T4RNA ligase 2. Analysis of the reactions of the
BC2- and BC6-loop pairs (3a:4a and 3b:4b) by PAGE sug-
gested the formation of the desired closed structures (dumb-
bells 2a and 2b, respectively; Figure 3B) as major products.
In both cases, we observed the formation of a new band
thatmigratedmore slowly than the starting hairpins. 5′- and
3′-exonuclease assays (Figure 3C and D) confirmed the de-
sired double-ligated closed structure of these RNAs. After
isolation (by PAGE) and incubation with the 3′-exonuclease
snake venom phosphodiesterase I (SNVPD), both products
of ligation (2a and 2b) remained untouched after 2 days
of incubation (Figure 3D). The same occurred when they
were treated with calf intestinal phosphatase (CIAP) and 5′-
exonuclease bovine spleen phosphodiesterase (BSP) (Figure
3C). In contrast to this, pre-ligated hairpins 3a and 4a and a
synthetic BC2-dumbbell-shapedRNAwith an internal nick
(6; Figure 1; that had been prepared as a control) were hy-
drolyzed in the presence of BSP and SNVPD (Figure 3C
and D). In the case of the ligation of the hairpins contain-
ing a more flexible loop (3c and 4c; BC8 loop), we observed
the formation of a major product of much lower mobility
than the products of the former ligations (2a and 2b) and
an almost undetectable band of similar mobility to that of
the BC2 and BC6-loop dumbbells 2a and 2b (Figure 3B),
which could not be isolated. After isolation of the product
of lower mobility (major product) treatment with CIAP–
BSP and SNVPD led to rapid hydrolysis, (Figure 3C and
D), confirming its nicked structure. Taken together, these
results suggest that the processes of hairpin formation and
ligation are less favorable in the cases of RNAs having more
flexible loops (BC8), which could be explained by the lower
degree of BC loop-RNA nucleobase stacking predicted by
our calculations for the final BC8-loop structure.
Having established conditions for dumbbell formation,
we applied them to the synthesis of a second group of dumb-
bells. With the aim of comparing our dumbbell design with
a known biostable dumbbell-shaped RNA (28), we focused
on the synthesis of BC2- and BC6-loop versions of an anti-
Firefly mRNA 24 bp dumbbell with loops of natural nu-
cleotides (10, Figure 1) described in the literature (dumb-
bells 9a,b; Figures 1 and 3A). In this case, the reactions
of ligation of the corresponding pairs of hairpins (7a:8a
and 7b:8b; BC2- and BC6-loops, respectively) proceeded
with high efficiency to give the desired closed structures
(9a,b; Figure 3B), which were confirmed by the 5′-exo- and
3′-exonuclease assays (Figure 3C and D). This can be at-
tributed to the higher G:C content of this sequence, which
might favor the process of formation of the hairpins, due to
their higher thermal stability.
Stability of RNA dumbbells and linear controls in human
serum and cell extracts
To determine their biological stability, the BCn-loop dumb-
bells and their corresponding linear siRNA and nicked
controls were incubated in 50% human serum at 37◦C.
To compare them with known nuclease-resistant dumbbell
structures, the serum stability of the 7 nt-loop version of
dumbbells 9a,b [10 (Figure 1 and Supplementary Figure
S3), which was synthesized according to the literature (28)]
was also evaluated. Figure 4 shows the degradation profile
of the most representative examples: the BC2- and BC6-
dumbbells 9a and 9b, their siRNA, 1-nicked and 7 nt-loop
versions (siRNAII, 6 and 10, respectively) and the 3′-BC2
modified linear analogue 11 (Figure 1), which was synthe-
sized as a control. Unmodified siRNA II displayed very low
stability. Complete degradation was observed in only 4 h.
The 1-nicked analogue 8 was hydrolyzed even faster. In-
terestingly, the BC-loop structures displayed strongly en-
hanced stability. The integrated intensities of the gel bands
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Figure 3. (A) Reaction of formation of the two sets of luciferase dumbbells used in our studies [targeting Renilla (2a-c) and Firefly (9a,b) mRNAs]. (B)
Analysis of the ligation reactions by denaturing 15% PAGE containing 25% formamide and 7M urea in 1X TBE. * means double-ligated dumbbell-shaped
structure. (C andD) Incubation ofRNAswith (C) calf intestinal phosphatase and bovine spleen phosphodiesterase and (D) snake venomphosphodiesterase
I (SNVPD). Analysis of the exonuclease digestions by 15% non-denaturing PAGE. All oligonucleotides were withdrawn at indicated points, separated and
visualized with SYBR Gold.
showed that ∼35% and 5% of the BC2-loop dumbbell 9a
remained untouched after 24 and 48 h of incubation, re-
spectively. Its BC6-loop analogue (9b) displayed similar sta-
bility, with 40% and 5% of intact RNA after 24 and 48 h.
In contrast, its 7 nt-loop dumbbell version (10) and the 3′-
BC2-modified dsRNA 11 were degraded in 12 and 24 h, re-
spectively.
To confirm that the BCn-loops also protect the RNA
from nuclease degradation in complex cellular mixtures, we
studied the degradation ofRNAs siRNA II, 6, 9a, 9b, 10 and
11 in 10% S100 cytosolic extract from HeLa cells (Supple-
mentary Figure S4) (41). As observed with human serum
(Figure 4), the BCn-loop-modified dumbbells (9a and 9b)
were significantly more stable than the corresponding 3′-
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Figure 4. 15% non-denaturing polyacrylamide gels of unmodified siRNA II, 7 nt-loop dumbbell 10, 3′-BC2-modified linear dsRNA 11, 1-nicked structure
6, BC2-loop and BC6-loop dumbbells 9a and 9b (respectively) incubated in phosphate buffered saline (PBS) containing 50% human serum at 37◦C. All
oligonucleotides were withdrawn at indicated points, separated by 15% native PAGE and visualized with SYBR Gold.
BC2-modified linear analogue and even higher than their
7 nt-loop version (10).
Thermal denaturation and circular dichroism studies
Connection of the ends of the duplex through a BC loop
gave a great increase in thermal stability (Supplementary
Figure S5). The melting temperatures (Tm) of the 24 bp
BC2- and BC6-loop dumbbells 9a and 9b were >25◦C
higher than that of their linear counterpart (LdsRNA24)
(>95◦C for 9a,b versus 73◦C for LdsRNA24) and slightly
higher than that of their 7 nt-loop analogue 10 (∼95◦C;
Supplementary Figure S5A). Similar results were obtained
for the second group of 29 bp structures (Tms of 79◦C and
77◦C for BC2- and BC6-dumbbells 2a and 2b, versus 54◦C
forLdsRNA29; Supplementary Figure S5B).Moreover, CD
analysis confirmed that the siRNA BC2- and BC6- capping
does not alter the structure of the double-helix. The CD
spectra of all the synthesized dumbbells superimposed well
to those of their siRNA analogues (Supplementary Figure
S6), confirming an A-type RNA-like structure.
RNA recognition and cleavage by Dicer
Dicer is aRNase III-likemulti-domain protein composed of
a DExH/DEAH RNA helicase domain, a PAZ signature,
two neighboring RNAse III-like domains and a dsRNA-
binding domain (3–5,42). The helicase domain promotes
translocation of the enzyme along the dsRNA and struc-
tural rearrangement of the substrate required for cleavage,
whereas PAZ binds to the 2 nt 3′ overhang of its dsRNA
substrate (43). It has been proposed that canonical Dicers
preferentially cleave dsRNAs possessing free termini, by
measuring from the 3′-end (bound to the PAZ domain) to
theRNase III active site (4).However, despite the absence of
freeRNAends in capped structures, dumbbell RNAs can be
processed by Dicer (28,29,44). The similarity of the dumb-
bell stem with a canonical A-like RNA duplex found in our
MD simulation suggest also that our constructs should be
substrates of Dicer.
In order to investigate the effect of the N-alkyl-N dimeric
nucleotides on Dicer recognition, all the synthesized BC-
dumbbells were incubated with recombinant human Dicer
and subjected to native gel electrophoresis. As shown in Fig-
ure 5, all the dumbbells were indeed recognized and digested
by the enzyme. In the case of the shorter dumbbells (24
bp; 9a and 9b), RNAs shorter than 20 bp were obtained as
the major products. Under the same conditions, the longer
dumbbell 2b (29 bp; BC6-loop) was digested almost com-
pletely to sequences of about 21 bp, which is in accordance
with length of the Dicer products of long dsRNAs (3–5),
whereas the less flexible 29 bp BC2-loop analogue 2a was
slowly digested to a mixture of shorter products. As ex-
pected (3), the treatment did not change siRNA I.
The above described results suggest that Dicer recognizes
this class of capped dsRNAs and that a decrease in the
lengths of the stem and the alkyl chain increases the de-
gree of resistance to Dicer cleavage, leading to longer diges-
tion times and shorter products. This could be attributed
to steric effects caused by the terminal loops over the Dicer
active site and to the lower flexibility of N-alkyl-N caps pos-
sessing short alkyl chains (see Figure 2D–F). Steric contacts
between the loop and Dicer residues might force the en-
zyme to bind to internal regions located far away from the
loops, which would lead to short processing products in the
case of shorter duplexes. On the other hand, the higher flex-
ibility predicted for the longer alkyl linkers might favor the
structural rearrangements (helicase-promoted) involved in
the digestion process.
RNAi activities of BCn-loop dumbbells targeting Renilla and
Firefly mRNAs
To investigate if our dumbbell designs can be processed
by Dicer not only in vitro, but also in vivo, we carried out
two parallel experiments with the two groups of BCn-loop
dumbbells [targeting Renilla (2a,b) and Firefly (9a,b) lu-
ciferases], with their corresponding siRNA controls [siRNA
I and siRNA II (Figure 1) as controls for dumbbells 2a,b
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Figure 5. Analysis of theDicer cleavage reaction of RNAdumbbells. Annealed RNAswere incubated with recombinant humanDicer at 37◦C, and aliquots
were withdrawn at 0, 1, 6 and 20 h. The reaction mixtures were analyzed by 15% native PAGE and visualized with SYBR Gold.
and 9a,b, respectively], their 7 nt-loop dumbbell analogues
[29 bp anti-Renilla dumbbell 5 and 24 bp anti-Firefly dumb-
bell 10; Figure 1 and Supplementary Figure S3; synthesized
by double ligation of 5′-phosphorylated dsRNAs, accord-
ing to the literature (28)] and with a non-targeting siRNA
(scr; Figure 1). HeLa cells were co-transfected with the dual
reporter plasmids pRL-TK and pGL3 and with the vari-
ous RNAs (20 nM), and the expression levels of the two lu-
ciferase genes were measured 24 h after transfection (Figure
6; panels A and B). Remarkably, all the dumbbells displayed
significant target reduction. By comparingRenilla and Fire-
fly dumbbells 2a,b (Figure 6A) and 9a,b (Figure 6B) with
their corresponding siRNA controls [siRNA I (Figure 6A)
and siRNA II (Figure 6B), respectively], we observed that
a BC6 loop is better tolerated than the shorter BC2 loop.
On the other hand, comparing RNAs 9a,b (Figure 6B) with
2a,b, (Figure 6A) andRNA 10with 5, we inferred that as the
stem length increased (from 24 to 29 bp, respectively), the
inhibitory effect (with respect to their unmodified siRNA
analogues) significantly improved. Finally, by comparing
BC2- and BC6-loop RNAs with their corresponding 7 nt-
loop analogues, we observed that the activities of 7 nt-loop
dumbbells are higher than that of the BC2-loop RNAs and
slightly lower than that of their BC6-loop counterparts. [(98
± 0.5)%, (78 ± 1.5)%, (91 ± 0.5)% and (88 ± 0.5)% gene
knockwdown for the 24 bp RNAs siRNA II, 9a, 9b and 10,
respectively (Figure 6B), and (88 ± 2)%, (80 ± 0.5)%, (84
± 1.5)% and (82 ± 0.5)% gene knockwdown for the 29 bp
RNAs siRNA I, 2a, 2b and 5 (Figure 6A)]. Themost promis-
ing design corresponded to the 29 bpBC6-loop dumbbell 2b
(Figure 6A). Although it showed suppression levels slightly
lower than that of its siRNA control [(84 ± 1.5)% for 2b
versus (88± 2)% for siRNA I; Figure 6A], a time-course ex-
periment revealed that it had prolonged activity. The 7 nt-
loop dumbbell analogue 5 also hadRNAi effect longer than
siRNA I, but the lifetime of its activity was lower than that
of BC6-loop dumbbell 2b. In a different experiment, HeLa
H/P cells stably overexpressing the Renilla and Firefly vec-
tors were transfected with 2b, 5 and siRNA I (25 nM), and
the RNAi activities of the three RNAs were compared over
a period of 6 days (Figure 6C). Very interestingly, on day 6,
the suppression activity of the BC6-dumbbell 2bwas signif-
icantly higher than that of RNAs siRNA I and 5 (7 nt-loop
analogue)[(45 ± 1.5%) gene knockdown for 2b versus (24
± 2%) and (34 ± 1)% for siRNA I and 5, respectively, P <
0.0001 and P < 0.001; Supplementary Figure S8].
Taken together, the results obtained from our RNAi ex-
periments in vivo are in good agreement with the digestion
pattern observed for in vitroDicer cleavage (Figure 5), sug-
gesting that capping the ends of the duplex with BCn loops
leads to a slow release of the functional RNAs, permit-
ting longer and then more effective RNAi effect. Our time-
course experiments suggest that the presence of 7 nt-loops
connecting the ends of the duplex causes a similar effect, al-
though significantly smaller than that observed in the case
of the BC6 loop.
Gene silencing activity of dumbbell RNA targeting GRB7
To further determine the scope of application of our nanos-
tructures, we decided to target an endogenous therapeuti-
cally relevant gene. We focused on GRB7 because of its
important role in breast cancer biology and its supposed
role in anti-cancer drug resistance (31,45–48). GRB7 is an
adaptor protein involved in receptor tyrosine kinase signal-
ing which has a key role in HER2 signaling, promoting cell
survival and migration (31). It has been reported that ex-
pression of GRB7 in the HER2 overexpressed breast can-
cer subtype contributes to the aggressive nature of the tu-
mor (45) and that HER2 signaling inhibition causes GRB7
upregulation. Moreover, it has also been demonstrated that
knockdown of GRB7 by RNA interference potentiates the
activity of HER2-targeting drugs (47), leading to decreases
in cell proliferation (45).
The most promising dumbbell design, (29 bp stem and
a BC6 loop), was used to synthesize a dumbbell target-
ing the 1019–1037 site of the GRB7 mRNA (GenBank
code: BC006535.2), using a previously described sequence
(dumbbell 14, Figure 1 and Figures S3 and S7) (49). For
comparison purposes, the corresponding 7 nt-loop ana-
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Figure 6. (A and B) Plots of specific activity for BCn- and 7 nt-loop dumbbells and unmodified siRNAs targeting the Renilla (2a,b, 5 and siRNA I; panel
A) and the Firefly (9a,b, 10 and siRNA II; panel B) luciferase mRNAs in HeLa cells. Cells were co-transfected with the dual reporter plasmids pRL-TK
and pGL3 and with the various RNAs, and the expression levels of the two luciferase genes were measured 24 h after transfection. Untreated cells: cells
treated with plasmids alone. (C) Time-course experiments with BC6-dumbbell 2b, 7 nt-loop dumbbell 5 and siRNA I targeting Renilla luciferase in HeLa
H/P cells stably overexpressing the Renilla and Firefly vectors. Untreated cells: cells treated with the transfection agent alone. In all cases, bars indicate
standard deviation.
logue (15) was also prepared [according to the literature
(28); Supplementary Figure S3]. Transfection with the non-
targeting control siRNA I (anti-Renilla luciferase siRNA)
served as a negative control. Levels of GRB7 protein af-
ter treating the HER2+ breast cancer cell line SKBR3 with
anti-GRB7 BC6- and 7 nt-loop dumbbells 14 and 15 and
with a known anti-GRB7 siRNAas positive control (siRNA
III; Figure 1) are shown in Figure 7A. In the three cases
(siRNA III and dumbbells 14 and 15), the inhibition of
GRB7 protein expression was very small on day 1, whereas
after 48 h, the GRB7 expression was reduced by 95%, 92%
and 78% in the cases of siRNA III and dumbbells 14 and 15,
respectively. Very interestingly, the inhibitory effect of the
BC6-loop dumbbell 14 was marked at 72 h and persisted
up to 6 days, whereas unmodified siRNA III, starts losing
efficiency after 72 h. Although the activity of the 7 nt-loop
dumbbell 15 was also marked at 72 h (100% GRB7 sup-
pression), it also started to decrease at this point, although
significantly slower than unmodified siRNA III. On day 6,
the suppression activity of the BC6-loop dumbbell 14 was
1.6-fold and 3.8-fold more potent than those of RNAs 15 (7
nt loop) and siRNA III, respectively, with cells treated with
dumbbell 14 showing a marginal 5% expression of GRB7.
These results were further confirmed using a different
siRNA sequence that had as target the 943–961 site of the
same mRNA (GRB7) (GenBank code: BC006535.2) (45).
The BC6-loop dumbbell directed against this second re-
gion (18; Figure 1; synthesized by double ligation of BC6-
loop hairpins 16 and 17; Supplementary Figure S7) in-
duced changes in gene expression profiles over the time-
course similar to the ones observed for anti-GRB7 BC6-
loop dumbbell used in our first series of studies (14, see
panels A and B in Figure 7). As observed in the first case
(dumbbell 14; Figure 7, panel A), on day 6, this second
BC6-loop dumbbell construct (18) displayed RNAi activity
significantly higher than its corresponding 7 nt-loop ana-
logue [19; which was also synthesized (28), for compari-
son purposes (Supplementary Figure S3)] and much higher
than the corresponding unmodified siRNA of the same se-
quence (siRNA IV), which was used as positive control (5%
of GRB7 expression for BC6-loop dumbbell 18 versus 15%
and 68% for 7 nt-loop dumbbell 19 and unmodified siRNA
IV, respectively). In contrast to what had been observed
for the first series of anti-GRB7 dumbbells (14 and 15),
both dumbbells 18 and 19 presented their maximum ac-
tivity at 48 h. BC6-dumbbell remained still completely ac-
tive at 72 h, whereas the 7 nt-loop analogue 15 underwent
a slight decrease in activity at this point (95% and 100%
GRB7 suppression at time points 72 and 48 h, respectively).
This difference in the delay of activity observed for the two
sets of anti-GRB7 dumbbells could be attributed to possi-
ble sequence-dependent effects on Dicer cleavage (50,51),
which might influence in the rate of processing and release
of the active RNA species.
Taken together, our results suggest that the longer-lived
RNAi activity observed for the BC6-loop dumbbell design
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Figure 7. (A and B) Representative immunoblots for GRB7 and -actin (internal control) from SKBR3 cells treated with (A) BC6-dumbbell 14, 7 nt-loop
dumbbell 15 and siRNA III targeting the 1019–1037 site of GRB7 mRNA and with (B) BC6-dumbbell 18, 7 nt-loop dumbbell 19 and siRNA IV targeting
the 943–961 site of GRB7 mRNA. In both cases (A and B) non-targeting siRNA I (60 nM) was used as negative control. (C and D) Proliferation assay
after transfection with BC6-dumbbell 14, siRNA III targeting the GRB7 mRNA and non-targeting control siRNA I (60 nM). The growth of (C) SKBR3
and (D) MCF7 cells were assessed using crystal violet assay and plotted as a percentage of proliferation relative to the vehicle control cells.
is due to the unique BCn-loop modification connecting the
ends of the RNA duplex. Although a standard dumbbell
RNA design (7 nt-loop; 15 and 19) confers greater duration
of action than a wt-siRNA, (see Figures 6C, 7A and B), our
results demonstrate that the BCn-loop design leads to even
longer-lived activity.
Finally, we evaluated the effect of dumbbell-mediated
GRB7 knockdown on cell proliferation, quantified on 48
and 72 h after RNA transfection using the crystal vio-
let cell viability assays in SKBR3 cells. Viability assays in
cells transfected with anti-GRB7 siRNA III and dumb-
bell 14 (targeting the 1019–1037 site) and with the nega-
tive (non-targeting) control siRNA I (Figure 7C) revealed
that 72 h after transfection, proliferation was significantly
lower in 14-transfected cells compared with unmodified
siRNA III-transfected cells [(66 ± 5)% cell proliferation
for 14 versus (82 ± 1)% for siRNA III; P < 0.05; Sup-
plementary Figure S9]. On the contrary, MCF7 cells, that
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do not have HER2 and GRB7 amplification, and express
very low levels of GRB7, were unaffected when treated un-
der the same conditions (Figure 7D). Very similar effects
were observed when we used the second group of anti-
GRB7 RNAs (siRNA IV, 18 and 19; targeting the 943–
961 site; see Supplementary Figure S10). In all cases, the
dumbbell structures displayed higher anti-proliferative ac-
tivity than natural siRNAs. In summary, BC6-loop dumb-
bell structures have excellent long-term inhibitory proper-
ties of the synthesis of GRB7––probably related to their
higher biostability––which is translated in an excellent an-
tiproliferation profile.
CONCLUSIONS
In summary, computational studies on dsRNAs contain-
ing 3′-terminal bridged N-alkyl-N dimeric nucleotides (BC
dimers) have allowed us to design new dumbbell-shaped
BC-loop RNA architectures with higher biostability than
their linear 3′-BC-modified version and the 7 nt-loop dumb-
bells described in the literature. The best dumbbell design,
corresponding to a BC-loop dimer with a 6 carbon atoms
alkyl linker and a stem length of 29 bp, could be used for
targeting the relevant GRB7 oncogene in SKBR3 breast
cancer cells with longer duration of action and higher anti-
proliferative effects than an unmodified siRNA. This class
of alteration represents a complementary siRNA modifi-
cation approach that might offer an avenue for the devel-
opment of new potentially active derivatives. As the BC-
loop N-alkyl-N bridged nucleosides have two free hydroxyl
groups, they could participate in the conjugation with other
biomolecules acting as delivery systems. The study of these
and other potential biomedical applications are currently
underway in our laboratory. Moreover, as our modification
is located at the ends of the RNA duplex, it could be used
in combination with conventional siRNA chemistries at se-
lected internal positions (51) to optimize the properties of
the siRNA molecule, giving rise to therapeutic RNAs with
even higher nuclease resistance.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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